Obserwuj
Swati Gupta
Swati Gupta
Alnylam Pharmaceuticals
Zweryfikowany adres z alnylam.com
Tytuł
Cytowane przez
Cytowane przez
Rok
Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
JK Nair, H Attarwala, A Sehgal, Q Wang, K Aluri, X Zhang, M Gao, J Liu, ...
Nucleic acids research 45 (19), 10969-10977, 2017
2152017
Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
CR Brown, S Gupta, J Qin, T Racie, G He, S Lentini, R Malone, M Yu, ...
Nucleic acids research 48 (21), 11827-11844, 2020
1652020
Reversal of siRNA-mediated gene silencing in vivo
I Zlatev, A Castoreno, CR Brown, J Qin, S Waldron, MK Schlegel, ...
Nature biotechnology 36 (6), 509-511, 2018
752018
MICROBIAL PRODUCTION OF STEVIOL GLYCOSIDES
R Philippe, AP Kumaran, J Donald, K Patel, S Gupta, R Lim, L LI
US Patent App. 15/524,015, 2017
202017
Reverse Transcription Quantitative Polymerase Chain Reaction Methods to Support Pharmacokinetics and Drug Mechanism of Action to Advance Development of RNA Interference …
YX Elena Castellanos-Rizaldos,Christopher R. Brown, Sean Dennin, Joohwan Kim ...
NUCLEIC ACID THERAPEUTICS, 2020
52020
Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes
A Clua, S Grijalvo, N Erande, S Gupta, K Yucius, R Gargallo, S Mazzini, ...
Molecules 27 (12), 3944, 2022
12022
Correction: Clua et al. Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes …
A Clua, S Grijalvo, N Erande, S Gupta, K Yucius, R Gargallo, S Mazzini, ...
Molecules 28 (1), 98, 2022
2022
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–7